Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
05/2008
05/08/2008WO2008012635A3 Amine derivatives useful as anticancer agents
05/08/2008WO2008011109A3 Substituted pyridone compounds and methods of use
05/08/2008WO2007135529A3 Azabenzimidazolyl compounds as mglur2 potentiators
05/08/2008WO2007072506A3 Polymorphic forms of dolasetron mesylate and processes thereof
05/08/2008US20080108820 First isolated from the sponge Hemiasterella; for treatment of cancer; prevention of restenosis of blood vessels subject to traumas such as angioplasty and stenting; methods for synthetic preparation
05/08/2008US20080108652 Acute/chronic inflammatory disease of peripheral organs and central nervous system (CNS)
05/08/2008US20080108651 5-[3-((R)(-)-5,7-Dibromo-1,2,3,4-tetrahydro-naphthalen-1-ylamino)-propylamino]-4H-thieno[3,2-b]pyridine-7-one; optically active; new target antibiotic, inhibitor of bacterial methionyl tRNA synthetase; antibiotic resistance; Clostridium difficile infection; mostly in immunodeficient, elderly
05/08/2008US20080108649 Bicyclic modulators of androgen receptor function
05/08/2008US20080108648 Novel imidazo[1,5-a] pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
05/08/2008US20080108645 Dihydrotetrabenazines And Pharmaceutical Compositions Containing Them
05/08/2008US20080108641 Compounds for treating inflammatory disorders, demyelinating disdorders and cancers
05/08/2008US20080108635 Triazolopyrimidine derivatives as ADP P2Y12 receptor antagonists
05/08/2008US20080108634 Novel phenylalanine derivatives
05/08/2008US20080108619 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
05/08/2008US20080108616 as serine/threonine, fusion, and tyrosine kinase receptors as nerve and fibroblast growth factor; abnormal activation of immune and nervous systems; antiproliferative; lung; 4-(3-Trifluoromethyl-phenylamino)-pyrrolo[2,3-d]pyrimidine-7-carboxylic acid [3-(4-morpholin-4-yl-phenylcarbamoyl)-phenyl]-amide
05/08/2008US20080108605 Anxiolytic agents with reduced sedative and ataxic effects
05/08/2008US20080108600 Polycyclic Pyridines as Potassium Ion Channel Modulators
05/08/2008US20080108591 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy
05/08/2008CA2668255A1 Anilinopiperazine derivatives and methods of use thereof
05/08/2008CA2668210A1 Anilinopiperazine derivatives and methods of use thereof
05/08/2008CA2668209A1 Anilinopiperazine derivatives and methods of use thereof
05/08/2008CA2666138A1 Kinase inhibitors
05/07/2008EP1918279A2 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and opioid receptor like receptor (ORL1) ligands for the treatment of pain
05/07/2008EP1918278A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
05/07/2008EP1917265A1 HETEROARYL-SUBSTiTUTED DIAZATRICYCLOALKANES, METHODS FOR ITS PREPARATION AND USE THEREOF
05/07/2008EP1917264A1 Novel 3,9-diaza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
05/07/2008EP1917263A1 Process for the preparation of imidazopyridines
05/07/2008EP1917262A1 Piperidine and piperazine derivatives as p2x3 antagonists
05/07/2008EP1917245A1 Heterocyclic compounds and their use as binding partners for 5-ht5 receptors
05/07/2008EP1725553B1 Tetrahydropyridoindole derivatives
05/07/2008EP1722795B1 Piperidinyl prostaglandin e analogs
05/07/2008EP1608627B1 Bicyclic anilide spirohydantoin cgrp receptor antagonists
05/07/2008EP1575963B1 Anti-angiogenetic therapeutic agents
05/07/2008EP1558600B1 Selected cgrp antagonists, method for production and use thereof as medicament
05/07/2008EP1539751B1 Process for the preparation of imidazo(1,2-a)pyridine-3-acetamides
05/07/2008CN101175756A Tricyclic spiro compound comprising acyl group bound to nitrogen atom in the ring
05/07/2008CN101175755A N- [3- (1-amin0-5, 6, 7, 8-tetrahydro-2 , 4, 4b-triazafluoren-9-yl)-phenyl] benzamides as tyrosine/threonine kinase inhibitors, in particular b-raf kinase
05/07/2008CN101175754A Novel tetrahydro-1h-pyrido [4,3-b] indole derivatives as cb1' receptor ligands
05/07/2008CN101175753A Compounds and compositions as protein kinase inhibitors
05/07/2008CN101172973A A process for the preparation of pyridine-methylsulfinyl compounds
05/07/2008CN101172930A 2.4-dihalogen-6-(C2-C3-alkyl)-phenyl substituted tetramic acid derivatives
05/06/2008US7368571 HIV-Integrase inhibitors, pharmaceutical compositions and methods for their use
05/06/2008US7368465 Metalloproteinase inhibitors
05/06/2008US7368459 Heterocyclic compounds
05/06/2008US7368458 N-(1-Benzyl-2-oxo-6-phenyl-1,2,3,4-tetrahydro-1,8-naphthyridin-3-yl)benzenesulfonamide; antagonists; regulation of appetite; obesity; smoking cessation
05/06/2008US7368453 Quinazolinone compounds with reduced bioaccumulation
05/06/2008US7368445 Fused pyrazole derivatives as TGF-β signal transduction inhibitors for the treatment of fibrosis and neoplasms
05/06/2008US7368444 4-Hydroxy-1-toluenesulfonyl-2,3,4,5-tetrahydro-1H-1-benzazepine, for example; useful as the preventive and/or treatment medicine against diseases caused by stress
05/06/2008US7368438 Non-nucleotide compositions and method for inhibiting platelet aggregation
05/06/2008CA2258949C Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
05/02/2008WO2008051757A1 Compositions and methods for modulating c-kit and pdgfr receptors
05/02/2008WO2008051493A2 Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors
05/02/2008WO2008050600A1 Therapeutic or preventive agent for intractable disease based on oxidative stress-mediated cell death as molecular background
05/02/2008WO2008049994A1 New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90
05/02/2008WO2008049855A2 7-azaindole derivatives as c-met kinase inhibitors
05/02/2008WO2008030511A3 Substituted 3,4,6,7-tetrahydro-5h, 1,2a,4a,8-tetraazacyclopenta[cd]phenalenes
05/02/2008WO2007109154A3 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
05/02/2008CA2667010A1 Compositions and methods for modulating c-kit and pdgfr receptors
05/02/2008CA2666618A1 Heteroaryl compounds, compositions thereof, and methods of treatment therewith
05/02/2008CA2664115A1 New fluorene derivatives, compositions containing the same and use thereof as inhibitors of the protein chaperone hsp 90
05/01/2008US20080103310 preparation of 4-amino-1H-imidazo[4,5-c]quinolines comprising the step of reacting a 1H-imidazo[4,5-c]quinolin-4-phthalimide with an amine selected from the group consisting of: alkylamine, aralkylamine, alkyldiamine, and aralkyldiamine.
05/01/2008US20080103188 Novel bicyclic compounds as modulators of androgen receptor function
05/01/2008US20080103164 methyl 6-chloro-1-(4-methylphenyl)-1,3,4,9-tetrahydro-2H- beta -carboline-2-carboxylate; antitumor agent; human papillomavirus, adenoviruses, retroviruses infections; sexually transmitted; head, neck cancers, skin cancers; warts, genital warts, cervical dysplasia, recurrent respiratory papillomatosis
05/01/2008US20080103161 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
05/01/2008US20080103156 Bicyclic Heteroaromatic Compounds
05/01/2008US20080103152 7-{4-[3-(2-chloro-3,6-difluorophenoxy)propyl]phenyl}-3,9-diazabicyclo [3.3.1]non-6-ene-6-carboxylic acid cyclopropyl-(2,3-dichlorobenzyl)amide; renin inhibitor; hypotensive agent, renal and cardial diseases, antidiabetic, antiinflammatory, anxiolitic agent, antidepressant
05/01/2008US20080103137 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases
05/01/2008US20080103136 3-[1-(2-chlorophenyl)ethoxy]-5-imidazo[1,2-a]pyridin-3-ylthiophene-2-carboxyamide; polo like kinase inhibitor; antitumor and anticarcinogenic agent; mitotic phase (M phase) of the cell cycle
05/01/2008US20080103135 Histamine H3 antagonists; do not contain imidazolyl moiety; such as 1-[4-(4-piperidin-1-ylmethyl-phenyl)-but-3-ynyl]-piperidine
05/01/2008US20080103132 Fused heterocyclic compounds
05/01/2008US20080102031 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H,1-benzopyran-2,4'-piperidine; ligands of delta opioid receptor; analgesic, anxiolitic, antidepressant, analgesic; gastrointestinal disorders, neurodegenerative diseases; side effect reduction
04/2008
04/30/2008EP1916249A1 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents
04/30/2008EP1915386A1 Metal complex
04/30/2008EP1915375A1 Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics
04/30/2008EP1915374A2 2-indolyl imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer
04/30/2008EP1915373A1 Heterobicyclic compounds useful as p38 kinase inhibiting agents
04/30/2008EP1915372A1 Indole derivatives as crth2 receptor antagonists
04/30/2008CN101171308A Fluoroquinolonoquinolones and inkjet ink compositions comprising the same
04/30/2008CN101171252A Tetracyclic azapyrazinoindolines as 5-HT2 ligands
04/30/2008CN101171247A Pyrrole derivatives as DNA gyrase and topoisomerase inhibitors
04/30/2008CN101171222A Terrylene and quaterrylene derivatives
04/30/2008CN101171008A Proton pump inhibitors in the treatment of sleep disturbance due to silent gastro-esophageal reflux
04/30/2008CN100384846C Fused azole-pyrimidine derivatives
04/30/2008CN100384843C CGRP receptor antagonists
04/30/2008CN100384842C 8-substituted imidazopyridines
04/30/2008CN100384836C Novel cyclic amide derivatives
04/30/2008CN100384825C Benzheterocyclic derivatives
04/30/2008CN100384423C Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
04/30/2008CN100384420C Use of substituted pyrazoles in preparing medicine compositions for treating allergies
04/30/2008CA2608608A1 A process for the preparation of pyridine-methylsulfinyl compounds
04/29/2008USRE40278 Heterocyclic amines having central nervous system activity
04/29/2008US7365211 Heterocyclic GABAA subtype selective receptor modulators
04/29/2008US7365089 Triazolo-quinolin derivatives useful as adenosine receptor ligands
04/29/2008US7365080 Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof
04/29/2008US7365079 2-(2-naphthyl)-4'-[3-oxospiro[6-azaisobenzofuran-1(3H),1-cyclohexan]-4'-yl]-1H-imidazole; metabolic, genitalor reproductive, gastro-intestinal, respiratory system disorders, antiinflammatory agent or glaucoma; cyclization
04/29/2008US7365078 Triaza-cyclopenta[cd]indene derivatives
04/29/2008US7365072 Inhibitors of p38
04/29/2008US7365070 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders
04/29/2008US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate
04/29/2008US7365066 Pyrazolopyridine derivatives as pharmaceutical agents